Intrinsic Value of S&P & Nasdaq Contact Us

Inspire Medical Systems, Inc. INSP NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
77/100
4/7 Pass
SharesGrow Intrinsic Value
$98.87
+74%
Analyst Price Target
$97.50
+71.6%

Inspire Medical Systems, Inc. (INSP) is a Medical - Devices company in the Healthcare sector, currently trading at $56.83. It has a SharesGrow Score of 77/100, indicating a strong investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of INSP = $98.87 (+74% from the current price, the stock appears undervalued). Analyst consensus target is INSP = $98 (+71.6% upside).

Valuation: INSP trades at a trailing Price-to-Earnings (P/E) of 10.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.37.

Financials: revenue is $912M, +31.8%/yr average growth. Net income is $145M, growing at +192.5%/yr. Net profit margin is 15.9% (healthy). Gross margin is 85.4% (+1.6 pp trend).

Balance sheet: total debt is $32M against $781M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 6.08 (strong liquidity). Debt-to-assets is 3.5%. Total assets: $907M.

Analyst outlook: 13 / 27 analysts rate INSP as buy (48%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 100/100 (Pass), Moat 66/100 (Partial), Future 52/100 (Partial), Income 70/100 (Pass).

$97.50
▲ 71.56% Upside
Average Price Target
Based on 27 Wall Street analysts offering 12-month price targets for Inspire Medical Systems, Inc., the average price target is $97.50, with a high forecast of $180.00, and a low forecast of $60.00.
Highest Price Target
$180.00
Average Price Target
$97.50
Lowest Price Target
$60.00

INSP SharesGrow Score Overview

77/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 66/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 70/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — INSP

VALUE Pass
100/100
INSP trades at a trailing Price-to-Earnings (P/E) of 10.9 (S&P 500 average ~25). Forward PEG 0.37 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.05. Analyst consensus target is $98, implying +72.4% from the current price $57. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
INSP: +31.8%/yr revenue is, +192.5%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
INSP: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet INSP: Debt-to-Equity (D/E) ratio 0.04 (conservative), Current ratio is 6.08 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
66/100
INSP: Gross margin is 85.4% (+1.6 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 66/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 13 / 27 analysts rate INSP as buy (48%). Analyst consensus target is $98 (+72.4% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
70/100
INSP: Net profit margin is 15.9%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range48.3-163.35
Volume890.44K
Avg Volume (30D)1.27M
Market Cap$1.64B
Beta (1Y)0.86
Share Statistics
EPS (TTM)4.95
Shares Outstanding$29.37M
IPO Date2018-05-03
Employees1,246
CEOTimothy Herbert
Financial Highlights & Ratios
Revenue (TTM)$911.98M
Gross Profit$778.76M
EBITDA$64.91M
Net Income$145.42M
Operating Income$50.95M
Total Cash$308.27M
Total Debt$32.16M
Net Debt$-72.66M
Total Assets$907.32M
Price / Earnings (P/E)11.5
Price / Sales (P/S)1.79
Analyst Forecast
1Y Price Target$85.00
Target High$180.00
Target Low$60.00
Upside+49.6%
Rating ConsensusHold
Analysts Covering27
Buy 48% Hold 52% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS4577301090

Price Chart

INSP
Inspire Medical Systems, Inc.  ·  NYSE
Healthcare • Medical - Devices
48.30 52WK RANGE 163.35
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message